Rat Pulmonary Artery Smooth Muscle Cells

Cat.No.: CSC-C4138X

Species: Rat

Source: Lung; Artery

Cell Type: Smooth Muscle Cell

  • Specification
  • Background
  • Scientific Data
  • Q & A
  • Customer Review
Cat.No.
CSC-C4138X
Description
Rat Pulmonary Artery Smooth Muscle Cells from Creative Bioarray are isolated from tissue of Sprague-Dawley Rats. Rat Pulmonary Artery Smooth Muscle Cells are grown in T75 tissue culture flasks pre-coated with gelatin-based coating solution for 0.5 hour and incubated in Creative Bioarray's Cell Culture Medium for 3-7 days. Cultures are then expanded. Prior to shipping, cells are detached from flasks and immediately cryo-preserved in vials. Each vial contains at least 1x10^6 cells per ml and is delivered frozen.
Cells are negative for bacteria, yeast, fungi, and mycoplasma and are characterized by immunofluorescent staining with antibodies to α-smooth muscle actin.
Cells can be expanded on a multiwell culture plate ready for experiments under the cell culture conditions specified by Creative Bioarray.
Repeated freezing and thawing of cells is not recommended.
Standard biochemical procedures performed with smooth muscle cell cultures include the assays of cell to cell interaction, PCR, Western blotting, immunoprecipitation, immunofluorescent staining, immunofluorescent flow cytometry or generating cell derivatives for desired research applications.
Species
Rat
Source
Lung; Artery
Recommended Medium
Complete Smooth Muscle Cell Medium
Cell Type
Smooth Muscle Cell
Disease
Normal
Storage and Shipping
Creative Bioarray ships frozen cells on dry ice. On receipt, immediately transfer frozen cells to liquid nitrogen (-180 °C) until ready for experimental use. Live cell shipment is also available on request.
Citation Guidance
If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no. If your paper has been published, please click here to submit the PubMed ID of your paper to get a coupon.

Rat Pulmonary Artery Smooth Muscle Cells (RPASMCs) are one of many cell types that comprise the pulmonary arterial system. As cells found in the medial layer of the pulmonary artery, RPASMCs maintain vascular tone and provide structural support. Pulmonary smooth muscle cells are highly plastic and transition between a "contractile phenotype" (regulating blood pressure) and "synthetic phenotype" (repairing/remodeling tissue). When cultured, they display a "hill-and-valley" pattern of proliferation and express cell surface markers such as α-smooth muscle actin (α-SMA) and smooth muscle myosin heavy chain (SM-MHC).

RPASMCs are often used to model Pulmonary Arterial Hypertension (PAH). Pulmonary artery smooth muscle cells are usually cited in papers examining possible molecular causes of PAH including cues that trigger vascular remodeling events such as hyper-proliferation and apoptosis-resistance during hypoxic exposures. Papers targeting HIF-signaling and dysregulation of Kv channels within PASMCs cause pulmonary vasoconstriction.

RPASMCs can also be used to study mechanotransduction from stretching and for high-throughput drug screening. Primary RPASMCs are the preferred in vitro assay to study calcium signaling and vasodilatory drugs because their responses best emulate the response of an intact rat lung before in vivo animal models are utilized.

PASMC primary cells were isolated from rat pulmonary arteries after hypoxia-induced pulmonary hypertension.

Fig. 1. PASMC primary cells were isolated from rat pulmonary arteries after hypoxia-induced pulmonary hypertension (Liu G, Zhang S Q, et al., 2023).

NCAM1 Contributes to the Proliferation and Migration of PDGF-BB-Induced PASMCs

Pulmonary hypertension (PH) involves pulmonary arterial remodeling. Neural cell adhesion molecule 1 (NCAM1) is a cell surface glycoprotein that participates in diverse diseases such as cardiovascular disease, but its role in PH remains unclear. Herein, Chen's team examined the role of NCAM1 in PDGF-BB-stimulated rat pulmonary artery smooth muscle cells (PASMCs). NCAM1 expression was significantly increased in PDGF-BB-stimulated PASMCs at the mRNA level (Fig. 1A) and protein level (Fig. 1B). To determine the roles of NCAM1, they knocked down NCAM1 expression with siRNA (Fig. 2A). NCAM1 knockdown partially inhibited PDGF-BB-induced PCNA increase (Fig. 2B) and suppressed PDGF-BB-induced cell proliferation (Fig. 2C and D) as assessed by CCK-8 assay and EdU incorporation assay. Moreover, NCAM1 knockdown inhibited PDGF-BB-induced PASMC migration (Fig. 2E, F).

NCAM1 expression is upregulated in PASMCs treated with PDGF-BB.

Fig. 1. NCAM1 expression is upregulated in PASMCs treated with PDGF-BB (Chen Y W, Liu N X, et al., 2024).

NCAM1 contributes to the proliferation and migration of PDGF-BB-induced PASMCs. PASMCs were treated with or without NCAM1 siRNA for 24 h before PDGF-BB (20 ng/mL, 24 h) treatment.

Fig. 2. NCAM1 contributes to the proliferation and migration of PDGF-BB-induced PASMCs. PASMCs were treated with or without NCAM1 siRNA for 24 h before PDGF-BB (20 ng/mL, 24 h) treatment (Chen Y W, Liu N X, et al., 2024).

Ask a Question

Write your own review

For research use only. Not for any other purpose.

Hot Products